5
Views
0
CrossRef citations to date
0
Altmetric
CNS Agents

Patent Evaluation: Heterocyclic Cholinesterase Inhibitors

Pages 1446-1447 | Published online: 02 Mar 2011
 

Summary

Novelty: Novel condensed heterocyclic compounds are disclosed, which are potentially useful as cholinesterase inhibitors and hence as therapeutic and prophylactic agents for senile dementia and Alzheimer's disease.

Biology: In an in vitro rat cerebral cortex assay for AChE inhibition, the most effective compound had an IC50 = 6.5 nM.

Chemistry: Syntheses of the compounds are described in thirty-three examples. 3-Methyl-7-[1-oxo-3-[1-(phenylmethyl)piperidin-4-yl]propyl]-2,3,4,5-tetrahydro-1H-3-benzazepine is one of ten specifically claimed examples.

Structure:

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.